ClinConnect ClinConnect Logo
Search / Trial NCT05681962

Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy

Launched by UNIVERSITY MAGNA GRAECIA · Jan 3, 2023

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Bronchoscopy

ClinConnect Summary

This clinical trial is studying how oxygen and breathing support are used for patients during a procedure called Fiberoptic Bronchoscopy (FOB), which is a way for doctors to look inside the lungs. The researchers want to understand how different breathing support methods work for patients with various lung conditions, like pneumonia or lung cancer, and how these methods may differ in different hospitals. By observing many patients, they aim to gather information about which approaches might be safer or more effective.

Anyone over the age of 18 who needs a Fiberoptic Bronchoscopy can join the study, regardless of whether they are visiting the hospital as an outpatient or are already admitted. Participants can expect that their doctors will take notes on their health before, during, and after the procedure, including any breathing support used and how well they recover. There are no specific exclusions, meaning almost anyone needing this procedure can participate. This study is important because it could help improve care for patients undergoing such procedures in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Need for any procedure with flexible FOB
  • Either outpatients in dedicated ambulatories, and admitted to any hospital ward or Intensive Care Unit (ICU)
  • Exclusion Criteria:
  • None

About University Magna Graecia

University Magna Graecia is a prestigious academic institution dedicated to advancing medical research and education. Located in Catanzaro, Italy, the university is committed to fostering innovation in clinical trials and promoting evidence-based healthcare practices. With a robust network of experienced researchers and clinicians, University Magna Graecia focuses on conducting high-quality clinical studies that aim to improve patient outcomes and contribute to the global medical community. Their research initiatives are characterized by a strong emphasis on ethical standards, collaboration, and the integration of cutting-edge scientific methodologies.

Locations

Catanzaro, , Italy

Patients applied

0 patients applied

Trial Officials

Federico Longhini, MD

Principal Investigator

Magna Graecia University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials